Post-Attendee Survey: "QI Strategies for LTBI Screening, Testing, and Treatment in A/AA and NH/PI-Serving Health Centers: National Clinical Quality Measure Development" Learning Collaborative

Question Title

* 1. Overall, how satisfied are you with this learning collaborative's first session on "Background on TB Prevention"?

5 - Extremely satisfied

4 - Very satisfied

3 - Moderately satisfied

2 - Somewhat satisfied

1 - Not at all satisfied

Question Title

* 2. How confident are you that you will be able to apply information from this learning collaborative's first session at your health center/organization?

5 - Extremely confident

4 - Very confident

3 - Moderately confident

2 - Somewhat confident

1 - Not at all confident

Question Title

* 3. Based on your level of knowledge prior to the learning collaborative's first session, how would you rate changes to your knowledge as a result of the learning collaborative's first session?

5 - Extremely high level of knowledge gained

4 - High level of knowledge gained

3 – Moderate level of knowledge gained

2 – Minimum level of knowledge gained

1 – No knowledge gained

Question Title

* 4. Name the most useful information, resource, or skill from this learning collaborative's first session that you’re likely to apply, try on, or share with colleagues within the next 90 days at your health center/organization.

Question Title

* 5. What will you change in your practice as a result of this training on "Background on TB Prevention"?

Question Title

* 6. Were the speakers' commercial relationship and types of relationship disclosed to the audience (either by announcement, distribution, slide or listed in the front of the syllabus) prior to the beginning of the activity? Alternatively, if speakers had no relationships to disclose, was the audience informed prior to the activity?

Yes

Question Title

* 7. CME activities are required to be evidence-based and bias free. Do you feel the presentations were balanced and free from commercial bias?

Yes

Please share feedback about each presenter.

Question Title

* 8. How effective was Jonathan Wortham as a presenter?

5 - Extremely effective

4 - Very effective

3 - Somewhat effective

2 - Not so effective

1 - Not at all effective

Question Title

* 9. How effective was the presentation by Jonathan Wortham?

5 - Extremely effective

4 - Very effective

3 - Somewhat effective

2 - Not so effective

1 - Not at all effective

Question Title

* 10. How effective was Kathryn Winglee as a presenter?

5 - Extremely effective

4 - Very effective

3 - Somewhat effective

2 - Not so effective

1 - Not at all effective

Question Title

* 11. How effective was the presentation by Kathryn Winglee?

5 - Extremely effective

4 - Very effective

3 - Somewhat effective

2 - Not so effective

1 - Not at all effective

Question Title

* 12. How did you learn about this learning collaborative opportunity? Select one or more.

HRSA Bureau of Primary Health Care (BPHC) Digest E-Mail

Health Center Resource Clearinghouse Website (www.healthcenterinfo.org)

AAPCHO Email Announcement

AAPCHO Website (www.aapcho.org)

Social Media - Twitter, Facebook, Linkedin, etc.

Word of Mouth

Other (please specify)

Question Title

* 13. First and Last Name

Question Title

* 14. Organization

Question Title

* 15. CME or CEU License # (if any):

Question Title

* 16. Do you have any additional comments or suggestions (e.g. feedback on the syllabus, agenda, learning objectives, faculty list, suggestions to improve learning collaboratives, presentations and other sessions, etc.)?

Post-Attendee Survey: "QI Strategies for LTBI Screening, Testing, and Treatment in A/AA and NH/PI-Serving Health Centers: National Clinical Quality Measure Development" Learning Collaborative

April 6, 2023 - SESSION 1: BACKGROUND ON TB PREVENTION

Question Title

* 1. Overall, how satisfied are you with this learning collaborative's first session on "Background on TB Prevention"?

Question Title

* 2. How confident are you that you will be able to apply information from this learning collaborative's first session at your health center/organization?

Question Title

* 3. Based on your level of knowledge prior to the learning collaborative's first session, how would you rate changes to your knowledge as a result of the learning collaborative's first session?

Question Title

* 4. Name the most useful information, resource, or skill from this learning collaborative's first session that you’re likely to apply, try on, or share with colleagues within the next 90 days at your health center/organization.

Question Title

* 5. What will you change in your practice as a result of this training on "Background on TB Prevention"?

Question Title

Question Title

* 7. CME activities are required to be evidence-based and bias free. Do you feel the presentations were balanced and free from commercial bias?

Question Title

* 8. How effective was Jonathan Wortham as a presenter?

Question Title

* 9. How effective was the presentation by Jonathan Wortham?

Question Title

* 10. How effective was Kathryn Winglee as a presenter?

Question Title

* 11. How effective was the presentation by Kathryn Winglee?

Question Title

* 12. How did you learn about this learning collaborative opportunity? Select one or more.

Question Title

* 13. First and Last Name

Question Title

* 14. Organization

Question Title

* 15. CME or CEU License # (if any):

Question Title

* 16. Do you have any additional comments or suggestions (e.g. feedback on the syllabus, agenda, learning objectives, faculty list, suggestions to improve learning collaboratives, presentations and other sessions, etc.)?